Anti-thymocyte globulin

And the hematologist there was amazing enough to recognize aplastic anemia pretty quickly, send my slides to a larger institution where the doctor, who's currently my doctor still, said, "Oh yeah, you better send her over here." And within, within three and a half weeks, which is a really rare situation, I was very fortunate to be diagnosed this quickly.

Within three or four weeks, I was getting ATG in the bone marrow transplant unit of a large hospital, and that's where the journey began.

[chuckles] At the time also Extremely fortunate was that my hematologist is a PNH specialist.

So he, it noted, and he said, "You have a very small PNH clone.

You know, there, there's recent ASH guidance on this, a recent How I Practice article on looking at guidelines for aplastic anemia, and, and one of those is sending for PNH testing.

So it's really, really important, and our listeners in the community, as you hear this, it's really important to keep this in mind, that a PNH clone can be associated with aplastic anemia and can expand potentially years later.

So I know ATG and cyclosporine and, and Promacta and that journey can be a challenging one when it comes to treatment of aplastic anemia.

And, and today, uh, y- you know, that's a whole separate episode or even just talk about that alone, getting ATG.

That's the goal.

Antithymocyte immunoglobulin is a combination of antibodies that act on or engage with T cells.

And T cells mediate cell killing in the immune system.

So If you think a little bit, it might not be technically 100% accurate, but as an autoimmune disease, meaning a patient has a hyperactive immune system, I mean, it shouldn't be killing self like pancreas.